APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medical Isotopes

A medical isotope is an isotope used in medicine. The first uses of isotopes in medicine were in radiopharmaceuticals, and this is still the most common use. However more recently, separated stable isotopes have also come into use.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A medical isotope is an isotope used in medicine. The first uses of isotopes in medicine were in radiopharmaceuticals, and this is still the most common use. However more recently, separated stable isotopes have also come into use.

In general, most isotope suppliers are not direct manufacturers because the direct manufacturers come from nuclear power plants. Isotope suppliers are generally authorized by the National Nuclear Energy Agency or signed an exclusive agreement. In addition, in the market, subsidiaries of the National Nuclear Energy Corporation are also the largest suppliers.

Selected research

Market Analysis & Forecast

Global Medical Isotopes Market Analysis and Forecast 2026-2032

31 December 2025208 pages

Choose your research edition.

Industry ResearchMedical Isotopes Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Isotopes Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Medical Isotopes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Isotopes Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Isotopes Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

A medical isotope is an isotope used in medicine. The first uses of isotopes in medicine were in radiopharmaceuticals, and this is still the most common use. However more recently, separated stable isotopes have also come into use.

In general, most isotope suppliers are not direct manufacturers because the direct manufacturers come from nuclear power plants. Isotope suppliers are generally authorized by the National Nuclear Energy Agency or signed an exclusive agreement. In addition, in the market, subsidiaries of the National Nuclear Energy Corporation are also the largest suppliers.

Many medical products today are sterilised by gamma rays from a Co-60 source, a technique which generally is much cheaper and more effective than steam heat sterilisation. The disposable syringe is an example of a product sterilised by gamma rays. Because it is a 'cold' process radiation can be used to sterilise a range of heat-sensitive items such as powders, ointments, and solutions, as well as biological preparations such as bone, nerve, and skin to be used in tissue grafts. Large-scale irradiation facilities for gamma sterilisation are installed in many countries. Smaller gamma irradiators, often utilising Cs-137, having a longer half-life, are used for treating blood for transfusions and for other medical applications. Sterilisation by radiation has several benefits. It is safer and cheaper because it can be done after the item is packaged. The sterile shelf-life of the item is then practically indefinite provided the seal is not broken. Apart from syringes, medical products sterilised by radiation include cotton wool, burn dressings, surgical gloves, heart valves, bandages, plastic, and rubber sheets and surgical instruments. Within the United States and other parts of the developed world, the trend has been to reduce the use of Co-60. And many U.S. hospitals have shifted to generating highly energetic beams with accelerator technology for such therapy. But much of the developing world still employs Co-60 mainly because of the capital costs associated with switching to alternative non-radioactive source technologies.

Read the full market overview

North America is the largest consumer by regions. Europe is the second largest with 26% market share. Asia Pacific s the following consumption region with 15% consumption market share. While the U.S. produces a significant number of the isotopes used by researchers, industry and the medical community, the U.S. is dependent upon foreign sources for many. Historically the U.S. provided almost all of the isotopes that were required for domestic consumption or, in special cases, acquired them from long-time allies. But beginning in the 1990’s other governments began to view the isotope industry as a high tech growth industry, and subsidized the production and sale of isotopes, targeting U.S. companies. The result is that U.S. industry has been switching its buying from the U.S. and DOE to foreign sources of supply.

Report Includes

This report presents an overview of global market for Medical Isotopes, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Medical Isotopes, also provides the revenue of main regions and countries. Of the upcoming market potential for Medical Isotopes, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Medical Isotopes revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Medical Isotopes market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Medical Isotopes revenue, projected growth trends, production technology, application and end-user industry.

Medical Isotopes Segment by Company

NRG

NTP Radioisotopes

JSC Isotope

ANSTO

IRE

Nordion

Curium Pharma

Cambridge Isotope Laboratories

Eckert & Ziegler Strahlen

Polatom

Center of Molecular Research

China National Nuclear Corporation

Urenco

LANL

Shanghai Engineering Research Center

IDB Holland

NHTC

Linde

ORNL

SI Science

Medical Isotopes Segment by Type

Stable Isotopes

Radioisotopes

Medical Isotopes Segment by Application

Nuclear Therapy

Equipment Radioactive Source

Diagnosis

Medical Isotopes Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Isotopes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Isotopes and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Isotopes.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Medical Isotopes in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Medical Isotopes company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Isotopes revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Medical Isotopes Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Stable Isotopes Major Player Table 3. Radioisotopes Major Player Table 4. Global Medical Isotopes Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Nuclear Therapy Major Player Table 6. Equipment Radioactive Source Major Player Table 7. Diagnosis Major Player Table 8. Medical Isotopes Industry Trends Table 9. Medical Isotopes Industry Drivers Table 10. Medical Isotopes Industry Opportunities and Challenges Table 11. Medical Isotopes Industry Restraints Table 12. Global Medical Isotopes Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Medical Isotopes Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Medical Isotopes Market Share by Region (2021-2026) Table 15. Global Medical Isotopes Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Medical Isotopes Market Share by Region (2027-2032) Table 17. Global Medical Isotopes Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Medical Isotopes Revenue Market Share by Players (2021-2026) Table 19. Global Medical Isotopes Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Medical Isotopes Key Players Headquarters & Area Served Table 21. Global Medical Isotopes Players, Product Type & Application Table 22. Global Medical Isotopes Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Medical Isotopes by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Medical Isotopes Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Medical Isotopes Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Medical Isotopes Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Medical Isotopes Revenue Market Share by Type (2021-2026) Table 29. Global Medical Isotopes Revenue Market Share by Type (2027-2032) Table 30. Global Medical Isotopes Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Medical Isotopes Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Medical Isotopes Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Medical Isotopes Revenue Market Share by Application (2021-2026) Table 34. Global Medical Isotopes Revenue Market Share by Application (2027-2032) Table 35. NRG Company Information Table 36. NRG Business Overview Table 37. NRG Medical Isotopes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. NRG Medical Isotopes Product Portfolio Table 39. NRG Recent Development Table 40. NTP Radioisotopes Company Information Table 41. NTP Radioisotopes Business Overview Table 42. NTP Radioisotopes Medical Isotopes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. NTP Radioisotopes Medical Isotopes Product Portfolio Table 44. NTP Radioisotopes Recent Development Table 45. JSC Isotope Company Information Table 46. JSC Isotope Business Overview Table 47. JSC Isotope Medical Isotopes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. JSC Isotope Medical Isotopes Product Portfolio Table 49. JSC Isotope Recent Development Table 50. ANSTO Company Information Table 51. ANSTO Business Overview Table 52. ANSTO Medical Isotopes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. ANSTO Medical Isotopes Product Portfolio Table 54. ANSTO Recent Development Table 55. IRE Company Information Table 56. IRE Business Overview Table 57. IRE Medical Isotopes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. IRE Medical Isotopes Product Portfolio Table 59. IRE Recent Development Table 60. Nordion Company Information Table 61. Nordion Business Overview Table 62. Nordion Medical Isotopes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Nordion Medical Isotopes Product Portfolio Table 64. Nordion Recent Development Table 65. Curium Pharma Company Information Table 66. Curium Pharma Business Overview Table 67. Curium Pharma Medical Isotopes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Curium Pharma Medical Isotopes Product Portfolio Table 69. Curium Pharma Recent Development Table 70. Cambridge Isotope Laboratories Company Information Table 71. Cambridge Isotope Laboratories Business Overview Table 72. Cambridge Isotope Laboratories Medical Isotopes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Cambridge Isotope Laboratories Medical Isotopes Product Portfolio Table 74. Cambridge Isotope Laboratories Recent Development Table 75. Eckert & Ziegler Strahlen Company Information Table 76. Eckert & Ziegler Strahlen Business Overview Table 77. Eckert & Ziegler Strahlen Medical Isotopes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Eckert & Ziegler Strahlen Medical Isotopes Product Portfolio Table 79. Eckert & Ziegler Strahlen Recent Development Table 80. Polatom Company Information Table 81. Polatom Business Overview Table 82. Polatom Medical Isotopes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Polatom Medical Isotopes Product Portfolio Table 84. Polatom Recent Development Table 85. Center of Molecular Research Company Information Table 86. Center of Molecular Research Business Overview Table 87. Center of Molecular Research Medical Isotopes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Center of Molecular Research Medical Isotopes Product Portfolio Table 89. Center of Molecular Research Recent Development Table 90. China National Nuclear Corporation Company Information Table 91. China National Nuclear Corporation Business Overview Table 92. China National Nuclear Corporation Medical Isotopes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. China National Nuclear Corporation Medical Isotopes Product Portfolio Table 94. China National Nuclear Corporation Recent Development Table 95. Urenco Company Information Table 96. Urenco Business Overview Table 97. Urenco Medical Isotopes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Urenco Medical Isotopes Product Portfolio Table 99. Urenco Recent Development Table 100. LANL Company Information Table 101. LANL Business Overview Table 102. LANL Medical Isotopes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. LANL Medical Isotopes Product Portfolio Table 104. LANL Recent Development Table 105. Shanghai Engineering Research Center Company Information Table 106. Shanghai Engineering Research Center Business Overview Table 107. Shanghai Engineering Research Center Medical Isotopes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Shanghai Engineering Research Center Medical Isotopes Product Portfolio Table 109. Shanghai Engineering Research Center Recent Development Table 110. IDB Holland Company Information Table 111. IDB Holland Business Overview Table 112. IDB Holland Medical Isotopes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. IDB Holland Medical Isotopes Product Portfolio Table 114. IDB Holland Recent Development Table 115. NHTC Company Information Table 116. NHTC Business Overview Table 117. NHTC Medical Isotopes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. NHTC Medical Isotopes Product Portfolio Table 119. NHTC Recent Development Table 120. Linde Company Information Table 121. Linde Business Overview Table 122. Linde Medical Isotopes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Linde Medical Isotopes Product Portfolio Table 124. Linde Recent Development Table 125. ORNL Company Information Table 126. ORNL Business Overview Table 127. ORNL Medical Isotopes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. ORNL Medical Isotopes Product Portfolio Table 129. ORNL Recent Development Table 130. SI Science Company Information Table 131. SI Science Business Overview Table 132. SI Science Medical Isotopes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. SI Science Medical Isotopes Product Portfolio Table 134. SI Science Recent Development Table 135. North America Medical Isotopes Revenue by Type (2021-2026) & (US$ Million) Table 136. North America Medical Isotopes Revenue by Type (2027-2032) & (US$ Million) Table 137. North America Medical Isotopes Revenue by Application (2021-2026) & (US$ Million) Table 138. North America Medical Isotopes Revenue by Application (2027-2032) & (US$ Million) Table 139. North America Medical Isotopes Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. North America Medical Isotopes Revenue by Country (2021-2026) & (US$ Million) Table 141. North America Medical Isotopes Revenue by Country (US$ Million) & (2027-2032) Table 142. Europe Medical Isotopes Revenue by Type (2021-2026) & (US$ Million) Table 143. Europe Medical Isotopes Revenue by Type (2027-2032) & (US$ Million) Table 144. Europe Medical Isotopes Revenue by Application (2021-2026) & (US$ Million) Table 145. Europe Medical Isotopes Revenue by Application (2027-2032) & (US$ Million) Table 146. Europe Medical Isotopes Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Europe Medical Isotopes Revenue by Country (2021-2026) & (US$ Million) Table 148. Europe Medical Isotopes Revenue by Country (US$ Million) & (2027-2032) Table 149. China Medical Isotopes Revenue by Type (2021-2026) & (US$ Million) Table 150. China Medical Isotopes Revenue by Type (2027-2032) & (US$ Million) Table 151. China Medical Isotopes Revenue by Application (2021-2026) & (US$ Million) Table 152. China Medical Isotopes Revenue by Application (2027-2032) & (US$ Million) Table 153. Asia Medical Isotopes Revenue by Type (2021-2026) & (US$ Million) Table 154. Asia Medical Isotopes Revenue by Type (2027-2032) & (US$ Million) Table 155. Asia Medical Isotopes Revenue by Application (2021-2026) & (US$ Million) Table 156. Asia Medical Isotopes Revenue by Application (2027-2032) & (US$ Million) Table 157. Asia Medical Isotopes Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 158. Asia Medical Isotopes Revenue by Region (US$ Million) & (2021-2026) Table 159. Asia Medical Isotopes Revenue by Region (US$ Million) & (2027-2032) Table 160. SAMEA Medical Isotopes Revenue by Type (2021-2026) & (US$ Million) Table 161. SAMEA Medical Isotopes Revenue by Type (2027-2032) & (US$ Million) Table 162. SAMEA Medical Isotopes Revenue by Application (2021-2026) & (US$ Million) Table 163. SAMEA Medical Isotopes Revenue by Application (2027-2032) & (US$ Million) Table 164. SAMEA Medical Isotopes Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. SAMEA Medical Isotopes Revenue by Country (2021-2026) & (US$ Million) Table 166. SAMEA Medical Isotopes Revenue by Country (US$ Million) & (2027-2032) Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Medical Isotopes Image Figure 2. Global Medical Isotopes Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Isotopes Market Size Share 2021 VS 2025 VS 2032 Figure 4. Stable Isotopes Image Figure 5. Radioisotopes Image Figure 6. Global Medical Isotopes Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Medical Isotopes Market Size Share 2021 VS 2025 VS 2032 Figure 8. Nuclear Therapy Image Figure 9. Equipment Radioactive Source Image Figure 10. Diagnosis Image Figure 11. Global Medical Isotopes Market Size (US$ Million) & (2021-2032) Figure 12. Global Medical Isotopes Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Medical Isotopes Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Medical Isotopes Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Medical Isotopes Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Medical Isotopes Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Medical Isotopes Revenue Market Share by Type (2021-2032) Figure 19. Global Medical Isotopes Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Medical Isotopes Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Medical Isotopes Revenue Market Share by Application (2021-2032) Figure 22. North America Medical Isotopes Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Medical Isotopes Revenue Share by Type (2021-2032) Figure 24. North America Medical Isotopes Revenue Share by Application (2021-2032) Figure 25. North America Medical Isotopes Revenue Share by Country (2021-2032) Figure 26. United States Medical Isotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Medical Isotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Medical Isotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Medical Isotopes Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Medical Isotopes Revenue Share by Type (2021-2032) Figure 31. Europe Medical Isotopes Revenue Share by Application (2021-2032) Figure 32. Europe Medical Isotopes Revenue Share by Country (2021-2032) Figure 33. Germany Medical Isotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Medical Isotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Medical Isotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Medical Isotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Medical Isotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Medical Isotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Medical Isotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Medical Isotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Medical Isotopes Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Medical Isotopes Revenue Share by Type (2021-2032) Figure 43. China Medical Isotopes Revenue Share by Application (2021-2032) Figure 44. Asia Medical Isotopes Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Medical Isotopes Revenue Share by Type (2021-2032) Figure 46. Asia Medical Isotopes Revenue Share by Application (2021-2032) Figure 47. Asia Medical Isotopes Revenue Share by Region (2021-2032) Figure 48. Japan Medical Isotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Medical Isotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Medical Isotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Medical Isotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Medical Isotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Medical Isotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Medical Isotopes Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Medical Isotopes Revenue Share by Type (2021-2032) Figure 56. SAMEA Medical Isotopes Revenue Share by Application (2021-2032) Figure 57. SAMEA Medical Isotopes Revenue Share by Country (2021-2032) Figure 58. Brazil Medical Isotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Medical Isotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Medical Isotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Medical Isotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Medical Isotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Medical Isotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Medical Isotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Medical Isotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Medical Isotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Medical Isotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Medical Isotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Stable Isotopes
  • Radioisotopes
Applications
  • Nuclear Therapy
  • Equipment Radioactive Source
  • Diagnosis
Companies covered
  • NRG
  • NTP Radioisotopes
  • JSC Isotope
  • ANSTO
  • IRE
  • Nordion
  • Curium Pharma
  • Cambridge Isotope Laboratories
  • Eckert & Ziegler Strahlen
  • Polatom
  • Center of Molecular Research
  • China National Nuclear Corporation
  • Urenco
  • LANL
  • Shanghai Engineering Research Center
  • IDB Holland
  • NHTC
  • Linde
  • ORNL
  • SI Science

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Medical Isotopes Market by Type
  3. 1.2.1 Global Medical Isotopes Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Stable Isotopes
  5. 1.2.3 Radioisotopes
  6. 1.3 Medical Isotopes Market by Application
  7. 1.3.1 Global Medical Isotopes Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Nuclear Therapy
  9. 1.3.3 Equipment Radioactive Source
  10. 1.3.4 Diagnosis
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Medical Isotopes Market Dynamics
  1. 2.1 Medical Isotopes Industry Trends
  2. 2.2 Medical Isotopes Industry Drivers
  3. 2.3 Medical Isotopes Industry Opportunities and Challenges
  4. 2.4 Medical Isotopes Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Medical Isotopes Market Perspective (2021-2032)
  2. 3.2 Global Medical Isotopes Growth Trends by Region
  3. 3.2.1 Global Medical Isotopes Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Medical Isotopes Market Size by Region (2021-2026)
  5. 3.2.3 Global Medical Isotopes Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Medical Isotopes Revenue by Players
  2. 4.1.1 Global Medical Isotopes Revenue by Players (2021-2026)
  3. 4.1.2 Global Medical Isotopes Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Medical Isotopes Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Medical Isotopes Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Medical Isotopes Key Players Headquarters & Area Served
  7. 4.4 Global Medical Isotopes Players, Product Type & Application
  8. 4.5 Global Medical Isotopes Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Medical Isotopes Market CR5 and HHI
  11. 4.6.3 2025 Medical Isotopes Tier 1, Tier 2, and Tier 3
5 Medical Isotopes Market Size by Type
  1. 5.1 Global Medical Isotopes Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Medical Isotopes Revenue by Type (2021-2032)
  3. 5.3 Global Medical Isotopes Revenue Market Share by Type (2021-2032)
6 Medical Isotopes Market Size by Application
  1. 6.1 Global Medical Isotopes Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Medical Isotopes Revenue by Application (2021-2032)
  3. 6.3 Global Medical Isotopes Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 NRG
  2. 7.1.1 NRG Company Information
  3. 7.1.2 NRG Business Overview
  4. 7.1.3 NRG Medical Isotopes Revenue and Gross Margin (2021-2026)
  5. 7.1.4 NRG Medical Isotopes Product Portfolio
  6. 7.1.5 NRG Recent Developments
  7. 7.2 NTP Radioisotopes
  8. 7.2.1 NTP Radioisotopes Company Information
  9. 7.2.2 NTP Radioisotopes Business Overview
  10. 7.2.3 NTP Radioisotopes Medical Isotopes Revenue and Gross Margin (2021-2026)
  11. 7.2.4 NTP Radioisotopes Medical Isotopes Product Portfolio
  12. 7.2.5 NTP Radioisotopes Recent Developments
  13. 7.3 JSC Isotope
  14. 7.3.1 JSC Isotope Company Information
  15. 7.3.2 JSC Isotope Business Overview
  16. 7.3.3 JSC Isotope Medical Isotopes Revenue and Gross Margin (2021-2026)
  17. 7.3.4 JSC Isotope Medical Isotopes Product Portfolio
  18. 7.3.5 JSC Isotope Recent Developments
  19. 7.4 ANSTO
  20. 7.4.1 ANSTO Company Information
  21. 7.4.2 ANSTO Business Overview
  22. 7.4.3 ANSTO Medical Isotopes Revenue and Gross Margin (2021-2026)
  23. 7.4.4 ANSTO Medical Isotopes Product Portfolio
  24. 7.4.5 ANSTO Recent Developments
  25. 7.5 IRE
  26. 7.5.1 IRE Company Information
  27. 7.5.2 IRE Business Overview
  28. 7.5.3 IRE Medical Isotopes Revenue and Gross Margin (2021-2026)
  29. 7.5.4 IRE Medical Isotopes Product Portfolio
  30. 7.5.5 IRE Recent Developments
  31. 7.6 Nordion
  32. 7.6.1 Nordion Company Information
  33. 7.6.2 Nordion Business Overview
  34. 7.6.3 Nordion Medical Isotopes Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Nordion Medical Isotopes Product Portfolio
  36. 7.6.5 Nordion Recent Developments
  37. 7.7 Curium Pharma
  38. 7.7.1 Curium Pharma Company Information
  39. 7.7.2 Curium Pharma Business Overview
  40. 7.7.3 Curium Pharma Medical Isotopes Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Curium Pharma Medical Isotopes Product Portfolio
  42. 7.7.5 Curium Pharma Recent Developments
  43. 7.8 Cambridge Isotope Laboratories
  44. 7.8.1 Cambridge Isotope Laboratories Company Information
  45. 7.8.2 Cambridge Isotope Laboratories Business Overview
  46. 7.8.3 Cambridge Isotope Laboratories Medical Isotopes Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Cambridge Isotope Laboratories Medical Isotopes Product Portfolio
  48. 7.8.5 Cambridge Isotope Laboratories Recent Developments
  49. 7.9 Eckert & Ziegler Strahlen
  50. 7.9.1 Eckert & Ziegler Strahlen Company Information
  51. 7.9.2 Eckert & Ziegler Strahlen Business Overview
  52. 7.9.3 Eckert & Ziegler Strahlen Medical Isotopes Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Eckert & Ziegler Strahlen Medical Isotopes Product Portfolio
  54. 7.9.5 Eckert & Ziegler Strahlen Recent Developments
  55. 7.10 Polatom
  56. 7.10.1 Polatom Company Information
  57. 7.10.2 Polatom Business Overview
  58. 7.10.3 Polatom Medical Isotopes Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Polatom Medical Isotopes Product Portfolio
  60. 7.10.5 Polatom Recent Developments
  61. 7.11 Center of Molecular Research
  62. 7.11.1 Center of Molecular Research Company Information
  63. 7.11.2 Center of Molecular Research Business Overview
  64. 7.11.3 Center of Molecular Research Medical Isotopes Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Center of Molecular Research Medical Isotopes Product Portfolio
  66. 7.11.5 Center of Molecular Research Recent Developments
  67. 7.12 China National Nuclear Corporation
  68. 7.12.1 China National Nuclear Corporation Company Information
  69. 7.12.2 China National Nuclear Corporation Business Overview
  70. 7.12.3 China National Nuclear Corporation Medical Isotopes Revenue and Gross Margin (2021-2026)
  71. 7.12.4 China National Nuclear Corporation Medical Isotopes Product Portfolio
  72. 7.12.5 China National Nuclear Corporation Recent Developments
  73. 7.13 Urenco
  74. 7.13.1 Urenco Company Information
  75. 7.13.2 Urenco Business Overview
  76. 7.13.3 Urenco Medical Isotopes Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Urenco Medical Isotopes Product Portfolio
  78. 7.13.5 Urenco Recent Developments
  79. 7.14 LANL
  80. 7.14.1 LANL Company Information
  81. 7.14.2 LANL Business Overview
  82. 7.14.3 LANL Medical Isotopes Revenue and Gross Margin (2021-2026)
  83. 7.14.4 LANL Medical Isotopes Product Portfolio
  84. 7.14.5 LANL Recent Developments
  85. 7.15 Shanghai Engineering Research Center
  86. 7.15.1 Shanghai Engineering Research Center Company Information
  87. 7.15.2 Shanghai Engineering Research Center Business Overview
  88. 7.15.3 Shanghai Engineering Research Center Medical Isotopes Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Shanghai Engineering Research Center Medical Isotopes Product Portfolio
  90. 7.15.5 Shanghai Engineering Research Center Recent Developments
  91. 7.16 IDB Holland
  92. 7.16.1 IDB Holland Company Information
  93. 7.16.2 IDB Holland Business Overview
  94. 7.16.3 IDB Holland Medical Isotopes Revenue and Gross Margin (2021-2026)
  95. 7.16.4 IDB Holland Medical Isotopes Product Portfolio
  96. 7.16.5 IDB Holland Recent Developments
  97. 7.17 NHTC
  98. 7.17.1 NHTC Company Information
  99. 7.17.2 NHTC Business Overview
  100. 7.17.3 NHTC Medical Isotopes Revenue and Gross Margin (2021-2026)
  101. 7.17.4 NHTC Medical Isotopes Product Portfolio
  102. 7.17.5 NHTC Recent Developments
  103. 7.18 Linde
  104. 7.18.1 Linde Company Information
  105. 7.18.2 Linde Business Overview
  106. 7.18.3 Linde Medical Isotopes Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Linde Medical Isotopes Product Portfolio
  108. 7.18.5 Linde Recent Developments
  109. 7.19 ORNL
  110. 7.19.1 ORNL Company Information
  111. 7.19.2 ORNL Business Overview
  112. 7.19.3 ORNL Medical Isotopes Revenue and Gross Margin (2021-2026)
  113. 7.19.4 ORNL Medical Isotopes Product Portfolio
  114. 7.19.5 ORNL Recent Developments
  115. 7.20 SI Science
  116. 7.20.1 SI Science Company Information
  117. 7.20.2 SI Science Business Overview
  118. 7.20.3 SI Science Medical Isotopes Revenue and Gross Margin (2021-2026)
  119. 7.20.4 SI Science Medical Isotopes Product Portfolio
  120. 7.20.5 SI Science Recent Developments
8 North America
  1. 8.1 North America Medical Isotopes Revenue (2021-2032)
  2. 8.2 North America Medical Isotopes Revenue by Type (2021-2032)
  3. 8.2.1 North America Medical Isotopes Revenue by Type (2021-2026)
  4. 8.2.2 North America Medical Isotopes Revenue by Type (2027-2032)
  5. 8.3 North America Medical Isotopes Revenue Share by Type (2021-2032)
  6. 8.4 North America Medical Isotopes Revenue by Application (2021-2032)
  7. 8.4.1 North America Medical Isotopes Revenue by Application (2021-2026)
  8. 8.4.2 North America Medical Isotopes Revenue by Application (2027-2032)
  9. 8.5 North America Medical Isotopes Revenue Share by Application (2021-2032)
  10. 8.6 North America Medical Isotopes Revenue by Country
  11. 8.6.1 North America Medical Isotopes Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Medical Isotopes Revenue by Country (2021-2026)
  13. 8.6.3 North America Medical Isotopes Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Medical Isotopes Revenue (2021-2032)
  2. 9.2 Europe Medical Isotopes Revenue by Type (2021-2032)
  3. 9.2.1 Europe Medical Isotopes Revenue by Type (2021-2026)
  4. 9.2.2 Europe Medical Isotopes Revenue by Type (2027-2032)
  5. 9.3 Europe Medical Isotopes Revenue Share by Type (2021-2032)
  6. 9.4 Europe Medical Isotopes Revenue by Application (2021-2032)
  7. 9.4.1 Europe Medical Isotopes Revenue by Application (2021-2026)
  8. 9.4.2 Europe Medical Isotopes Revenue by Application (2027-2032)
  9. 9.5 Europe Medical Isotopes Revenue Share by Application (2021-2032)
  10. 9.6 Europe Medical Isotopes Revenue by Country
  11. 9.6.1 Europe Medical Isotopes Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Medical Isotopes Revenue by Country (2021-2026)
  13. 9.6.3 Europe Medical Isotopes Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Medical Isotopes Revenue (2021-2032)
  2. 10.2 China Medical Isotopes Revenue by Type (2021-2032)
  3. 10.2.1 China Medical Isotopes Revenue by Type (2021-2026)
  4. 10.2.2 China Medical Isotopes Revenue by Type (2027-2032)
  5. 10.3 China Medical Isotopes Revenue Share by Type (2021-2032)
  6. 10.4 China Medical Isotopes Revenue by Application (2021-2032)
  7. 10.4.1 China Medical Isotopes Revenue by Application (2021-2026)
  8. 10.4.2 China Medical Isotopes Revenue by Application (2027-2032)
  9. 10.5 China Medical Isotopes Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Medical Isotopes Revenue (2021-2032)
  2. 11.2 Asia Medical Isotopes Revenue by Type (2021-2032)
  3. 11.2.1 Asia Medical Isotopes Revenue by Type (2021-2026)
  4. 11.2.2 Asia Medical Isotopes Revenue by Type (2027-2032)
  5. 11.3 Asia Medical Isotopes Revenue Share by Type (2021-2032)
  6. 11.4 Asia Medical Isotopes Revenue by Application (2021-2032)
  7. 11.4.1 Asia Medical Isotopes Revenue by Application (2021-2026)
  8. 11.4.2 Asia Medical Isotopes Revenue by Application (2027-2032)
  9. 11.5 Asia Medical Isotopes Revenue Share by Application (2021-2032)
  10. 11.6 Asia Medical Isotopes Revenue by Country
  11. 11.6.1 Asia Medical Isotopes Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Medical Isotopes Revenue by Country (2021-2026)
  13. 11.6.3 Asia Medical Isotopes Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Medical Isotopes Revenue (2021-2032)
  2. 12.2 SAMEA Medical Isotopes Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Medical Isotopes Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Medical Isotopes Revenue by Type (2027-2032)
  5. 12.3 SAMEA Medical Isotopes Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Medical Isotopes Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Medical Isotopes Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Medical Isotopes Revenue by Application (2027-2032)
  9. 12.5 SAMEA Medical Isotopes Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Medical Isotopes Revenue by Country
  11. 12.6.1 SAMEA Medical Isotopes Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Medical Isotopes Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Medical Isotopes Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst